Endoscopic ultrasound‐guided fine‐needle aspiration for the diagnosis of solid pancreatic masses: the impact on patient‐management strategy

Summary Background  Endoscopic ultrasound‐guided fine‐needle aspiration (EUS‐FNA) is a safe and accurate technique for diagnosing pancreatic cancer. However, its impact for management of these patients is poorly investigated. Aims  To investigate the diagnostic yield and the therapeutic impact of EU...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2009-11, Vol.30 (10), p.1070-1077
Hauptverfasser: TOUCHEFEU, Y., LE RHUN, M., CORON, E., ALAMDARI, A., HEYMANN, M. F., MOSNIER, J. F., MATYSIAK, T., GALMICHE, J. P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1077
container_issue 10
container_start_page 1070
container_title Alimentary pharmacology & therapeutics
container_volume 30
creator TOUCHEFEU, Y.
LE RHUN, M.
CORON, E.
ALAMDARI, A.
HEYMANN, M. F.
MOSNIER, J. F.
MATYSIAK, T.
GALMICHE, J. P.
description Summary Background  Endoscopic ultrasound‐guided fine‐needle aspiration (EUS‐FNA) is a safe and accurate technique for diagnosing pancreatic cancer. However, its impact for management of these patients is poorly investigated. Aims  To investigate the diagnostic yield and the therapeutic impact of EUS‐FNA in the management of solid pancreatic masses. Methods  One hundred consecutive patients who underwent EUS‐FNA for a solid pancreatic mass were included. Aspirates were placed onto glass slides for cytological examination and microbiopsies were fixed in formaldehyde for histology. The impact on clinical management was analysed retrospectively according to different endpoints, such as its impact on indications for chemotherapy, surgery or appropriate follow‐up modality. Results  Eight procedures were considered failures and two patients were lost to follow‐up. A final diagnosis was obtained in 90 patients. The sensitivity, specificity and accuracy of combined cytology and histology for the diagnosis of malignant or potentially‐malignant tumours were 78%, 75%, and 78% respectively. The sensitivity and accuracy of cytology alone were significantly higher than those of histology alone (P = 0.0003). By intention‐to‐diagnose analysis, EUS‐FNA directly influenced the management strategy in 62 of 100 patients. Conclusions  In patients with pancreatic mass and suspected malignancy, EUS‐FNA provides an accurate diagnosis in approximately 80% of cases. EUS‐FNA directly influences the management in two‐thirds of patients.
doi_str_mv 10.1111/j.1365-2036.2009.04138.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733889187</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733889187</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5458-8b4a23c130061300f19fa6dcf18350efc5d9a3253dc606829a994928a03065d33</originalsourceid><addsrcrecordid>eNqNkc1u1DAQxyMEotvCKyBfgFOCP-LERuJQVS0gVYJDOVuuPxavEjt4EtG98QjwijwJTndVbggfbI_m958Z-19ViOCGlPVm1xDW8Zpi1jUUY9ngljDR3D2qNg-Jx9UG007WVBB2Up0C7DDGXY_p0-qEyJ5xyuim-nUZbQKTpmDQMsxZQ1qi_f3j53YJ1lnkQ3Qlis7ZwSENU8h6DikinzKavzpkg97GBAFQ8gjSECyadDTZFcygUQM4eHtPhnHSZkZFO5Wci3OpO-qot24sAYLSfHbb_bPqidcDuOfH86z6cnV5c_Ghvv70_uPF-XVteMtFLW5bTZkhrDxq3TyRXnfWeCIYx84bbqVmlDNrOtwJKrWUraRCY4Y7bhk7q14f6k45fVsczGoMYNww6OjSAqpnTAhJRF_IV_8kKSF9J1pcQHEATU4A2Xk15TDqvFcEq9U4tVOrP2r1R63GqXvj1F2Rvjj2WG5HZ_8Kj04V4OUR0GD04HP55AAPHKW4bTlfh3134L6Hwe3_ewB1_vlmvbE_6jC4tw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21176840</pqid></control><display><type>article</type><title>Endoscopic ultrasound‐guided fine‐needle aspiration for the diagnosis of solid pancreatic masses: the impact on patient‐management strategy</title><source>Wiley Free Content</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>TOUCHEFEU, Y. ; LE RHUN, M. ; CORON, E. ; ALAMDARI, A. ; HEYMANN, M. F. ; MOSNIER, J. F. ; MATYSIAK, T. ; GALMICHE, J. P.</creator><creatorcontrib>TOUCHEFEU, Y. ; LE RHUN, M. ; CORON, E. ; ALAMDARI, A. ; HEYMANN, M. F. ; MOSNIER, J. F. ; MATYSIAK, T. ; GALMICHE, J. P.</creatorcontrib><description>Summary Background  Endoscopic ultrasound‐guided fine‐needle aspiration (EUS‐FNA) is a safe and accurate technique for diagnosing pancreatic cancer. However, its impact for management of these patients is poorly investigated. Aims  To investigate the diagnostic yield and the therapeutic impact of EUS‐FNA in the management of solid pancreatic masses. Methods  One hundred consecutive patients who underwent EUS‐FNA for a solid pancreatic mass were included. Aspirates were placed onto glass slides for cytological examination and microbiopsies were fixed in formaldehyde for histology. The impact on clinical management was analysed retrospectively according to different endpoints, such as its impact on indications for chemotherapy, surgery or appropriate follow‐up modality. Results  Eight procedures were considered failures and two patients were lost to follow‐up. A final diagnosis was obtained in 90 patients. The sensitivity, specificity and accuracy of combined cytology and histology for the diagnosis of malignant or potentially‐malignant tumours were 78%, 75%, and 78% respectively. The sensitivity and accuracy of cytology alone were significantly higher than those of histology alone (P = 0.0003). By intention‐to‐diagnose analysis, EUS‐FNA directly influenced the management strategy in 62 of 100 patients. Conclusions  In patients with pancreatic mass and suspected malignancy, EUS‐FNA provides an accurate diagnosis in approximately 80% of cases. EUS‐FNA directly influences the management in two‐thirds of patients.</description><identifier>ISSN: 0269-2813</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/j.1365-2036.2009.04138.x</identifier><identifier>PMID: 19735232</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Biopsy, Fine-Needle ; Diagnostic Errors ; Digestive system ; Endoscopy ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Medical sciences ; Middle Aged ; Pancreas - diagnostic imaging ; Pancreas - pathology ; Pancreatic Neoplasms - diagnosis ; Pancreatic Neoplasms - diagnostic imaging ; Pancreatic Neoplasms - pathology ; Pharmacology. Drug treatments ; Sensitivity and Specificity ; Ultrasonography</subject><ispartof>Alimentary pharmacology &amp; therapeutics, 2009-11, Vol.30 (10), p.1070-1077</ispartof><rights>2009 Blackwell Publishing Ltd</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5458-8b4a23c130061300f19fa6dcf18350efc5d9a3253dc606829a994928a03065d33</citedby><cites>FETCH-LOGICAL-c5458-8b4a23c130061300f19fa6dcf18350efc5d9a3253dc606829a994928a03065d33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2036.2009.04138.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2036.2009.04138.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22044557$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19735232$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TOUCHEFEU, Y.</creatorcontrib><creatorcontrib>LE RHUN, M.</creatorcontrib><creatorcontrib>CORON, E.</creatorcontrib><creatorcontrib>ALAMDARI, A.</creatorcontrib><creatorcontrib>HEYMANN, M. F.</creatorcontrib><creatorcontrib>MOSNIER, J. F.</creatorcontrib><creatorcontrib>MATYSIAK, T.</creatorcontrib><creatorcontrib>GALMICHE, J. P.</creatorcontrib><title>Endoscopic ultrasound‐guided fine‐needle aspiration for the diagnosis of solid pancreatic masses: the impact on patient‐management strategy</title><title>Alimentary pharmacology &amp; therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><description>Summary Background  Endoscopic ultrasound‐guided fine‐needle aspiration (EUS‐FNA) is a safe and accurate technique for diagnosing pancreatic cancer. However, its impact for management of these patients is poorly investigated. Aims  To investigate the diagnostic yield and the therapeutic impact of EUS‐FNA in the management of solid pancreatic masses. Methods  One hundred consecutive patients who underwent EUS‐FNA for a solid pancreatic mass were included. Aspirates were placed onto glass slides for cytological examination and microbiopsies were fixed in formaldehyde for histology. The impact on clinical management was analysed retrospectively according to different endpoints, such as its impact on indications for chemotherapy, surgery or appropriate follow‐up modality. Results  Eight procedures were considered failures and two patients were lost to follow‐up. A final diagnosis was obtained in 90 patients. The sensitivity, specificity and accuracy of combined cytology and histology for the diagnosis of malignant or potentially‐malignant tumours were 78%, 75%, and 78% respectively. The sensitivity and accuracy of cytology alone were significantly higher than those of histology alone (P = 0.0003). By intention‐to‐diagnose analysis, EUS‐FNA directly influenced the management strategy in 62 of 100 patients. Conclusions  In patients with pancreatic mass and suspected malignancy, EUS‐FNA provides an accurate diagnosis in approximately 80% of cases. EUS‐FNA directly influences the management in two‐thirds of patients.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Biopsy, Fine-Needle</subject><subject>Diagnostic Errors</subject><subject>Digestive system</subject><subject>Endoscopy</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pancreas - diagnostic imaging</subject><subject>Pancreas - pathology</subject><subject>Pancreatic Neoplasms - diagnosis</subject><subject>Pancreatic Neoplasms - diagnostic imaging</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>Pharmacology. Drug treatments</subject><subject>Sensitivity and Specificity</subject><subject>Ultrasonography</subject><issn>0269-2813</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1u1DAQxyMEotvCKyBfgFOCP-LERuJQVS0gVYJDOVuuPxavEjt4EtG98QjwijwJTndVbggfbI_m958Z-19ViOCGlPVm1xDW8Zpi1jUUY9ngljDR3D2qNg-Jx9UG007WVBB2Up0C7DDGXY_p0-qEyJ5xyuim-nUZbQKTpmDQMsxZQ1qi_f3j53YJ1lnkQ3Qlis7ZwSENU8h6DikinzKavzpkg97GBAFQ8gjSECyadDTZFcygUQM4eHtPhnHSZkZFO5Wci3OpO-qot24sAYLSfHbb_bPqidcDuOfH86z6cnV5c_Ghvv70_uPF-XVteMtFLW5bTZkhrDxq3TyRXnfWeCIYx84bbqVmlDNrOtwJKrWUraRCY4Y7bhk7q14f6k45fVsczGoMYNww6OjSAqpnTAhJRF_IV_8kKSF9J1pcQHEATU4A2Xk15TDqvFcEq9U4tVOrP2r1R63GqXvj1F2Rvjj2WG5HZ_8Kj04V4OUR0GD04HP55AAPHKW4bTlfh3134L6Hwe3_ewB1_vlmvbE_6jC4tw</recordid><startdate>200911</startdate><enddate>200911</enddate><creator>TOUCHEFEU, Y.</creator><creator>LE RHUN, M.</creator><creator>CORON, E.</creator><creator>ALAMDARI, A.</creator><creator>HEYMANN, M. F.</creator><creator>MOSNIER, J. F.</creator><creator>MATYSIAK, T.</creator><creator>GALMICHE, J. P.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>200911</creationdate><title>Endoscopic ultrasound‐guided fine‐needle aspiration for the diagnosis of solid pancreatic masses: the impact on patient‐management strategy</title><author>TOUCHEFEU, Y. ; LE RHUN, M. ; CORON, E. ; ALAMDARI, A. ; HEYMANN, M. F. ; MOSNIER, J. F. ; MATYSIAK, T. ; GALMICHE, J. P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5458-8b4a23c130061300f19fa6dcf18350efc5d9a3253dc606829a994928a03065d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Biopsy, Fine-Needle</topic><topic>Diagnostic Errors</topic><topic>Digestive system</topic><topic>Endoscopy</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pancreas - diagnostic imaging</topic><topic>Pancreas - pathology</topic><topic>Pancreatic Neoplasms - diagnosis</topic><topic>Pancreatic Neoplasms - diagnostic imaging</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>Pharmacology. Drug treatments</topic><topic>Sensitivity and Specificity</topic><topic>Ultrasonography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TOUCHEFEU, Y.</creatorcontrib><creatorcontrib>LE RHUN, M.</creatorcontrib><creatorcontrib>CORON, E.</creatorcontrib><creatorcontrib>ALAMDARI, A.</creatorcontrib><creatorcontrib>HEYMANN, M. F.</creatorcontrib><creatorcontrib>MOSNIER, J. F.</creatorcontrib><creatorcontrib>MATYSIAK, T.</creatorcontrib><creatorcontrib>GALMICHE, J. P.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TOUCHEFEU, Y.</au><au>LE RHUN, M.</au><au>CORON, E.</au><au>ALAMDARI, A.</au><au>HEYMANN, M. F.</au><au>MOSNIER, J. F.</au><au>MATYSIAK, T.</au><au>GALMICHE, J. P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Endoscopic ultrasound‐guided fine‐needle aspiration for the diagnosis of solid pancreatic masses: the impact on patient‐management strategy</atitle><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>2009-11</date><risdate>2009</risdate><volume>30</volume><issue>10</issue><spage>1070</spage><epage>1077</epage><pages>1070-1077</pages><issn>0269-2813</issn><eissn>1365-2036</eissn><abstract>Summary Background  Endoscopic ultrasound‐guided fine‐needle aspiration (EUS‐FNA) is a safe and accurate technique for diagnosing pancreatic cancer. However, its impact for management of these patients is poorly investigated. Aims  To investigate the diagnostic yield and the therapeutic impact of EUS‐FNA in the management of solid pancreatic masses. Methods  One hundred consecutive patients who underwent EUS‐FNA for a solid pancreatic mass were included. Aspirates were placed onto glass slides for cytological examination and microbiopsies were fixed in formaldehyde for histology. The impact on clinical management was analysed retrospectively according to different endpoints, such as its impact on indications for chemotherapy, surgery or appropriate follow‐up modality. Results  Eight procedures were considered failures and two patients were lost to follow‐up. A final diagnosis was obtained in 90 patients. The sensitivity, specificity and accuracy of combined cytology and histology for the diagnosis of malignant or potentially‐malignant tumours were 78%, 75%, and 78% respectively. The sensitivity and accuracy of cytology alone were significantly higher than those of histology alone (P = 0.0003). By intention‐to‐diagnose analysis, EUS‐FNA directly influenced the management strategy in 62 of 100 patients. Conclusions  In patients with pancreatic mass and suspected malignancy, EUS‐FNA provides an accurate diagnosis in approximately 80% of cases. EUS‐FNA directly influences the management in two‐thirds of patients.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>19735232</pmid><doi>10.1111/j.1365-2036.2009.04138.x</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0269-2813
ispartof Alimentary pharmacology & therapeutics, 2009-11, Vol.30 (10), p.1070-1077
issn 0269-2813
1365-2036
language eng
recordid cdi_proquest_miscellaneous_733889187
source Wiley Free Content; MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Adult
Aged
Aged, 80 and over
Biological and medical sciences
Biopsy, Fine-Needle
Diagnostic Errors
Digestive system
Endoscopy
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Medical sciences
Middle Aged
Pancreas - diagnostic imaging
Pancreas - pathology
Pancreatic Neoplasms - diagnosis
Pancreatic Neoplasms - diagnostic imaging
Pancreatic Neoplasms - pathology
Pharmacology. Drug treatments
Sensitivity and Specificity
Ultrasonography
title Endoscopic ultrasound‐guided fine‐needle aspiration for the diagnosis of solid pancreatic masses: the impact on patient‐management strategy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T20%3A10%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Endoscopic%20ultrasound%E2%80%90guided%20fine%E2%80%90needle%20aspiration%20for%20the%20diagnosis%20of%20solid%20pancreatic%20masses:%20the%20impact%20on%20patient%E2%80%90management%20strategy&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=TOUCHEFEU,%20Y.&rft.date=2009-11&rft.volume=30&rft.issue=10&rft.spage=1070&rft.epage=1077&rft.pages=1070-1077&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/j.1365-2036.2009.04138.x&rft_dat=%3Cproquest_cross%3E733889187%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21176840&rft_id=info:pmid/19735232&rfr_iscdi=true